Zhongzhu Medical Holdings Co Ltd (600568) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.78 Million ≈ $3.92 Million USD) by net assets (CN¥1.71 Billion ≈ $250.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhongzhu Medical Holdings Co Ltd (600568) total market value for the company's overall valuation and market capitalisation.
Zhongzhu Medical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Zhongzhu Medical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhongzhu Medical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their cash flow conversion efficiency. Explore 600568 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CEWE Stiftung & Co. KGaA
XETRA:CWC
|
-0.010x |
|
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
|
0.027x |
|
Xingtong Shipping Co. Ltd.
SHG:603209
|
N/A |
|
indie Semiconductor Inc
NASDAQ:INDI
|
-0.090x |
|
Daqo New Energy Corp
F:5DQ2
|
-0.022x |
|
Shenyang Jinbei Automotive Co Ltd
SHG:600609
|
0.204x |
|
Beijing North Star Co Ltd Class A
SHG:601588
|
0.076x |
|
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
|
0.059x |
Annual Cash Flow Conversion Efficiency for Zhongzhu Medical Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Zhongzhu Medical Holdings Co Ltd from 1999 to 2025. View 600568 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.63 Billion ≈ $238.63 Million |
CN¥56.08 Million ≈ $8.21 Million |
0.034x | +83.70% |
| 2024-12-31 | CN¥1.74 Billion ≈ $255.02 Million |
CN¥32.63 Million ≈ $4.77 Million |
0.019x | +1649.82% |
| 2023-12-31 | CN¥2.59 Billion ≈ $379.07 Million |
CN¥2.77 Million ≈ $405.57K |
0.001x | -87.69% |
| 2022-12-31 | CN¥2.94 Billion ≈ $429.73 Million |
CN¥25.52 Million ≈ $3.74 Million |
0.009x | -65.54% |
| 2021-12-31 | CN¥3.73 Billion ≈ $545.62 Million |
CN¥94.04 Million ≈ $13.76 Million |
0.025x | -59.55% |
| 2020-12-31 | CN¥3.98 Billion ≈ $582.38 Million |
CN¥248.15 Million ≈ $36.31 Million |
0.062x | -60.51% |
| 2019-12-31 | CN¥3.89 Billion ≈ $569.54 Million |
CN¥614.57 Million ≈ $89.93 Million |
0.158x | +351.03% |
| 2018-12-31 | CN¥4.26 Billion ≈ $622.92 Million |
CN¥-267.76 Million ≈ $-39.18 Million |
-0.063x | -7.91% |
| 2017-12-31 | CN¥6.15 Billion ≈ $899.41 Million |
CN¥-358.29 Million ≈ $-52.43 Million |
-0.058x | -218.18% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.82 Million |
CN¥296.58 Million ≈ $43.40 Million |
0.049x | -30.98% |
| 2015-12-31 | CN¥2.65 Billion ≈ $387.06 Million |
CN¥189.05 Million ≈ $27.66 Million |
0.071x | +1185.81% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.47 Million |
CN¥14.34 Million ≈ $2.10 Million |
0.006x | +84.24% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.51 Million |
CN¥3.56 Million ≈ $520.44K |
0.003x | +106.40% |
| 2012-12-31 | CN¥1.03 Billion ≈ $150.39 Million |
CN¥-48.43 Million ≈ $-7.09 Million |
-0.047x | +42.30% |
| 2011-12-31 | CN¥915.88 Million ≈ $134.02 Million |
CN¥-74.80 Million ≈ $-10.94 Million |
-0.082x | +88.58% |
| 2010-12-31 | CN¥742.77 Million ≈ $108.69 Million |
CN¥-531.24 Million ≈ $-77.74 Million |
-0.715x | -91.30% |
| 2009-12-31 | CN¥677.27 Million ≈ $99.11 Million |
CN¥-253.20 Million ≈ $-37.05 Million |
-0.374x | -353.89% |
| 2008-12-31 | CN¥616.24 Million ≈ $90.17 Million |
CN¥90.74 Million ≈ $13.28 Million |
0.147x | +2020.96% |
| 2007-12-31 | CN¥514.98 Million ≈ $75.36 Million |
CN¥3.58 Million ≈ $523.18K |
0.007x | -93.14% |
| 2006-12-31 | CN¥479.24 Million ≈ $70.13 Million |
CN¥48.49 Million ≈ $7.10 Million |
0.101x | -1.27% |
| 2005-12-31 | CN¥558.76 Million ≈ $81.76 Million |
CN¥57.27 Million ≈ $8.38 Million |
0.102x | +1726.33% |
| 2004-12-31 | CN¥489.48 Million ≈ $71.63 Million |
CN¥2.75 Million ≈ $401.95K |
0.006x | +380.94% |
| 2003-12-31 | CN¥472.91 Million ≈ $69.20 Million |
CN¥551.80K ≈ $80.75K |
0.001x | -8.44% |
| 2002-12-31 | CN¥444.66 Million ≈ $65.07 Million |
CN¥566.66K ≈ $82.92K |
0.001x | -87.95% |
| 2001-12-31 | CN¥433.47 Million ≈ $63.43 Million |
CN¥4.59 Million ≈ $671.09K |
0.011x | -69.40% |
| 2000-12-31 | CN¥82.36 Million ≈ $12.05 Million |
CN¥2.85 Million ≈ $416.77K |
0.035x | -64.08% |
| 1999-12-31 | CN¥69.76 Million ≈ $10.21 Million |
CN¥6.72 Million ≈ $982.65K |
0.096x | -- |
About Zhongzhu Medical Holdings Co Ltd
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more